Results may vary.

Rituxan with glucocorticoids is the first FDA-approved medicine for people ages 2 years and above with Granulomatosis with Polyangiitis (GPA) (formerly known as Wegener's Granulomatosis) and Microscopic Polyangiitis (MPA).